0001746473-26-000039
SEC filingPliant Therapeutics, Inc. issued a press release on March 11, 2026, announcing the Company’s financial results under Item 2.02. The filing includes Exhibit 99.1, the press release, and references Item 9.01 for financial statements and exhibits.